Business ❯Acquisitions

Pharmaceutical Companies

GSK Novo Nordisk Orchard Therapeutics

GSK Acquires US Biotech IDRx in $1.15 Billion Deal to Advance Rare Cancer Treatment

FDA Approves Revolutionary $4.25 Million Gene Therapy for Rare Genetic Disorder